tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
PremiumRatingsInstil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
2M ago
Instil Bio Reports Promising Phase 2 Study Results
Premium
Company Announcements
Instil Bio Reports Promising Phase 2 Study Results
3M ago
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
Premium
The Fly
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
3M ago
Instil Bio Elects Director and Ratifies Auditor
PremiumCompany AnnouncementsInstil Bio Elects Director and Ratifies Auditor
5M ago
Instil Bio Advances Phase 2 Trial in China
Premium
Company Announcements
Instil Bio Advances Phase 2 Trial in China
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Instil Bio price target lowered to $105 from $110 at H.C. Wainwright
PremiumThe FlyInstil Bio price target lowered to $105 from $110 at H.C. Wainwright
5M ago
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
Premium
The Fly
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
5M ago
Instil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
Premium
The Fly
Instil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100